... an animal. These results show promise in the creation of new attenuated ('live virus') anti-viral vaccines and are reported in the journal Science ...
... virus, a finding that may have significant implications for HIV vaccine development. They report their findings in the December 2008 ... natural infection," say the researchers. "Indeed, this is the case for some other viral vaccines, such as those for hepatitis B and human papillomavirus ...
... per microgram than other types of vaccines, such as the chemically inactivated subunit viral vaccine currently used in the United ... for the buck," Compans says. Some next steps in the development of the vaccine are to find out if it can also protect against infection by mutant ...
... -7) – a key component of the immune system – with a viral vaccine to improve the ability of the cells of the immune ... response to tumours. This is important because current vaccine approaches for immune therapy induce a response ...
... protein levels and perhaps this understanding would lead to new advances in gene therapy and viral vaccinations ...
... , which are safer than "live" vaccines, have been largely unsuccessful for many non-viral diseases, including illnesses like ... or severely attenuated non-viral vaccines to work – and for viral vaccines to work better – it's necessary ...
... and more at 37°C with only tiny losses in the amount of viral vaccine re-obtained from the membrane. When required ... successfully stabilised a wide range of viral and conventional vaccines. "This new technique of drug delivery ...
... also explains why CMV might be a useful viral vaccine vector. Vaccine vectors are modified viruses ... vaccine vectors can only be used once. Because of their ability to overcome vector-directed immunity, CMV viral ...
... range of viruses." One way to make an anti-viral vaccine is to weaken a virus to the point where ... is a general one, and may allow the creation of safe, effective vaccines against many different types of viruses. In the future ...
... doses of insulin-sensitizing drugs might be useful as vaccine adjuvants, particularly for people with weakened immune ... years. (Adjuvants are added to some vaccines but not all. For example, live viral vaccines given during childhood ...
... infections, leading scientists to reevaluate their approaches to viral vaccine development. Researchers from the institute's Immunology ... activated properly. If we want to make an effective vaccine, we need to look at these early escape points ...
Researchers in Australia have discovered how a key viral gene helps viruses evade early detection ... are able to establish chronic infections, leading scientists to reevaluate their approaches to viral vaccine development ...
... Leo Stamatatos, Ph.D., director of the Viral Vaccines Program at Seattle BioMed and a major ... , which are the type of antibodies researchers wish to elicit by vaccination. "We've found that the people who develop broadly-reactive ...
... Grail” is to stimulate immunity that lasts for a lifetime. Live viral vaccines such as the smallpox or yellow fever ... could play a role.” One injection of the live viral yellow fever vaccine, developed in the 1930s by Nobel ...
... Grail' is to stimulate immunity that lasts for a lifetime. Live viral vaccines such as the smallpox or yellow fever vaccines provide immune protection that lasts several decades, but despite ...
